Details of the Drug Formulations

General Information of Drug (ID: DMG6ZU4)

• Drug Name: Lanreotide acetate Drug Info
• Synonyms: Lanreotide; Angiopeptin acetate; Somatuline; Somatulin; 127984-74-1; DC 13-116; Autogel; 108736-35-2; BIM 23014; Bim-23014; Lanreotide [INN:BAN]; Lanreotidum [INN-Latin]; Lanreotida [INN-Spanish]; Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2; 10-(4-Aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide; Somatuline lp (TN); Lanreotide Autogel

Indication

Disease Entry	ICD 11	Status	REF
Acromegaly	5A60.0	Approved	[1]

• Cross-matching ID:
  PubChem CID: 71349
  CAS Number: 108736-35-2
  TTD ID: D0M2YE
  ACDINA ID: D01195

Full List of Drug Formulations Containing This Drug

Lanreotide Acetate eq 60mg base/0.2ml solution

Company	Formulation ID	FDA Description
Ipsen Pharma	F24075	Water For Injection

Lanreotide Acetate eq 90mg base/0.3ml solution

Company	Formulation ID	FDA Description
Ipsen Pharma	F24076	Water For Injection

Lanreotide Acetate eq 120mg base/0.5ml solution

Company	Formulation ID	FDA Description
Ipsen Pharma	F24077	Water For Injection

References

• [1] Treatment strategies for acromegaly. Expert Opin Emerg Drugs. 2005 Nov;10(4):875-90.